Core Insights - Celanese reported revenue of $2.39 billion for Q1 2025, a decrease of 8.5% year-over-year, with EPS at $0.57 compared to $2.08 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $2.26 billion by 5.49%, while the EPS surpassed the consensus estimate of $0.37 by 54.05% [1] Financial Performance - Net Sales from the Acetyl Chain were $1.12 billion, above the average estimate of $1.08 billion, but down 11.5% year-over-year [4] - Net Sales from Inter segment eliminations were -$14 million, better than the estimated -$25.25 million, reflecting a 50% decrease compared to the previous year [4] - Net Sales from Engineered Materials reached $1.29 billion, exceeding the estimate of $1.18 billion, but down 6.6% year-over-year [4] - Operating EBITDA for the Acetyl Chain was $229 million, below the estimate of $245.41 million [4] - Operating EBITDA for Other Activities was -$50 million, better than the estimated -$55.99 million [4] - Operating EBITDA for Engineered Materials was $235 million, surpassing the estimate of $197.28 million [4] Stock Performance - Celanese shares have returned +12.1% over the past month, outperforming the Zacks S&P 500 composite's +0.4% change [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance in the near term [3]
Celanese (CE) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates